KeyBanc comments on Stevanato and West Pharma weakness, defends against perceived oral risk
Street Takeaways - GLP-1 Rx Tracker for week ended Jan 16th; Wegovy Pill uptake signicantly accelerates
StreetAccount Sector Summary - Healthcare Pre-Market
StreetAccount Summary - Trading higher/lower: EU mid-morning
Novo Nordisk trading higher; Wegovy pill reportedly hits c20k prescriptions in week 2 (DKK 408.40, +11.65)
StreetAccount Themes APAC Headlines (22-Jan)
StreetAccount Sector Summary - Healthcare Post-Market
Novo Nordisk and Aspect Biosystems enter new phase of partnership to develop curative medicines for diabetes; Novo Nordisk will make additional equity investment in Aspect (DKK 383.85, +6.30)
StreetAccount Sector Summary - Healthcare Weekly Recap
Powered by FactSet Research Systems Inc.